Your browser doesn't support javascript.
loading
Exploring the potential of routine serological markers in predicting neurological outcomes in spinal cord injury.
Matthias, Jan; Lukas, Louis P; Brüningk, Sarah C; Maier, Doris; Mach, Orpheus; Grassner, Lukas; Kramer, John L K; Bourguignon, Lucie; Jutzeler, Catherine R.
Afiliación
  • Matthias J; Department of Health Sciences and Technology (D-HEST), ETH Zurich, Universitätstrasse 2, 8092 Zürich, Switzerland; Schulthess Klinik, Lengghalde 2, 8008 Zürich, Switzerland; SIB Swiss Institute of Bioinformatics, Switzerland. Electronic address: jmatthias@student.ethz.ch.
  • Lukas LP; Department of Health Sciences and Technology (D-HEST), ETH Zurich, Universitätstrasse 2, 8092 Zürich, Switzerland; Schulthess Klinik, Lengghalde 2, 8008 Zürich, Switzerland; SIB Swiss Institute of Bioinformatics, Switzerland. Electronic address: louis.lukas@hest.ethz.ch.
  • Brüningk SC; Department of Health Sciences and Technology (D-HEST), ETH Zurich, Universitätstrasse 2, 8092 Zürich, Switzerland; Schulthess Klinik, Lengghalde 2, 8008 Zürich, Switzerland; SIB Swiss Institute of Bioinformatics, Switzerland. Electronic address: sarah.brueningk@hest.ethz.ch.
  • Maier D; Spinal Cord Injury Center, Trauma Center Murnau, Murnau, Germany. Electronic address: doris.maier@bgu-murnau.de.
  • Mach O; Spinal Cord Injury Center, Trauma Center Murnau, Murnau, Germany. Electronic address: orpheus.mach@bgu-murnau.de.
  • Grassner L; Spinal Cord Injury Center, Trauma Center Murnau, Murnau, Germany; Department of Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria; Institute of Molecular Regenerative Medicine, Paracelsus Medical University, Salzburg, Austria.
  • Kramer JLK; International Collaboration on Repair Discoveries (ICORD), University of British Columbia, Vancouver, Canada; Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Djavad Mowafaghian Centre for Brain H
  • Bourguignon L; Department of Health Sciences and Technology (D-HEST), ETH Zurich, Universitätstrasse 2, 8092 Zürich, Switzerland; Schulthess Klinik, Lengghalde 2, 8008 Zürich, Switzerland; SIB Swiss Institute of Bioinformatics, Switzerland. Electronic address: lucie.bourguignon@hest.ethz.ch.
  • Jutzeler CR; Department of Health Sciences and Technology (D-HEST), ETH Zurich, Universitätstrasse 2, 8092 Zürich, Switzerland; Schulthess Klinik, Lengghalde 2, 8008 Zürich, Switzerland; SIB Swiss Institute of Bioinformatics, Switzerland. Electronic address: catherine.jutzeler@hest.ethz.ch.
Exp Neurol ; 380: 114918, 2024 Oct.
Article en En | MEDLINE | ID: mdl-39142367
ABSTRACT
Spinal cord injury (SCI) is a rare condition with a heterogeneous presentation, making the prediction of recovery challenging. However, serological markers have been shown to be associated with severity and long-term recovery following SCI. Therefore, our investigation aimed to assess the feasibility of translating this association into a prediction of the lower extremity motor scores (LEMS) at chronic stage (52 weeks after initial injury) in patients with SCI using routine serological markers. Serological markers, assessed within the initial seven days post-injury in the observational cohort study from the Trauma Hospital Murnau underwent diverse feature engineering approaches. These involved arithmetic measurements such as mean, median, minimum, maximum, and range, as well as considerations of the frequency of marker testing and whether values fell within the normal range. To predict LEMS scores at the chronic stage, eight different regression models (including linear, tree-based, and ensemble models) were used to quantify the predictive value of serological markers relative to a baseline model that relied on the very acute LEMS score and patient age alone. The inclusion of serological markers did not improve the performance of the prediction model. The best-performing approach including serological markers achieved a mean absolute error (MAE) of 6.59 (2.14), which was equivalent to the performance of the baseline model. As an alternative approach, we trained separate models based on the LEMS observed at the very acute stage after injury. Specifically, we considered individuals with an LEMS of 0 or an LEMS exceeding zero separately. This strategy led to a mean improvement in MAE across all cohorts and models, of 1.20 (2.13). We conclude that, in our study, routine serological markers hold limited power for prediction of LEMS. However, the implementation of model stratification by the very acute LEMS markedly enhanced prediction performance. This observation supports the inclusion of clinical knowledge in the modeling of prediction tasks for SCI recovery. Additionally, it lays the path for future research to consider stratified analyses when investigating the predictive power of potential biomarkers.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Traumatismos de la Médula Espinal / Biomarcadores / Recuperación de la Función Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Neurol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Traumatismos de la Médula Espinal / Biomarcadores / Recuperación de la Función Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Exp Neurol Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos